Exit
-
Indian-origin Dr Vinay Prasad returns to FDA weeks after exit; Laura Loomer calls it ‘egregious choice’
Dr Vinay Prasad is again at his FDA job weeks after exit that was prompted…
-
Antfin Plans INR 3,800 Cr Block Deal To Exit Paytm: Report
SUMMARY Antfin Holding BV, a part of Alibaba Group, plans to promote its remaining 5.84%…
